When We Talks

Biotech startup building research facility in Vancouver, B.C. for radiotherapies lands $75M – GeekWire


Alpha-9 Theranostics, a Vancouver, B.C. and Boston-based biotech company developing radiotherapies, raised $75 million. The company was founded by researchers from the University of British Columbia and BC Cancer, and is led by David Hirsch, a venture partner at Longitude Capital, which led a previous $11 million Series A funding round. The company is building a research facility in Vancouver to advance development of its agents that selectively target radioisotopes to cancer cells. Nextech Invest led the Series B round, with participation from Longitude and other investors.


Source link

Related posts

Portland healthcare startup GrowthPlug acquired amid slowdown in exit activity – GeekWire

Effie Weber

After Seattle launch, personal assistant service Yohana goes nationwide to help more busy families – GeekWire

Effie Weber

BlackRock leads $100M round for Cap Hill Brands; e-commerce vets acquire 35 brands, add key execs – GeekWire

Effie Weber